Skip to main content
. 2022 Mar 16;47(1):1–25. doi: 10.1093/jat/bkac017

Table V.

Oral Dosage, Onset Time, Duration of Effects and Half-life of Selected DBZDs (59–62)

Compound “Recreational” oral doses [mg] Onset [min] Duration of effects [h] Half- life [h]
3-Hydroxyphenazepam 0.5–4 30–90 24 N/A
Clonazolam 0.2–1 20–60 6–10 3.6
Deschloroetizolam 4–6 1–5 8–10 N/A
Diclazepam 2–4 15–90 8–12 42
Etizolam 0.25–3
Therapeutic: 0.5–2.0
30–120 5–8 3.4–7.1
Flualprazolam 0.125–2.5 10–30 6–14 9.5–12
Flubromazepam 4–8 15–90 12–18 106
Flubromazolam 0.15–0.25 20–45 Sedation for 10 h,
Partial amnesia >24 h
Possibly 30 h
Flunitrazolam 0.08–0.15 10–30 4–5 N/A
Meclonazepam 2–3 20–60 9–15 80
Metizolam 2 30–90 5–8 N/A
Nifoxipam 0.5–3.0 45–120 10–75 N/A
Norflurazepam
(N-desalkylflurazepam)
5–10 45–120 10–16 40–250
Phenazepam 3–5
Therapeutic: max. 10
15–60 >18 15–60
Pyrazolam 0.5–4 10–25 5–8 17